Crossmark

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience

Crossref DOI link: https://doi.org/10.1007/s10549-018-4684-3

Published Online: 2018-02-01

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Figura, Nicholas B.

Long, Wendy

Yu, Michael

Robinson, Timothy J.

Mokhtari, Sepideh

Etame, Arnold B.

Tran, Nam D.

Diaz, Roberto

Soliman, Hatem

Han, Heather S.

Sahebjam, Solmaz

Forsyth, Peter A.

Ahmed, Kamran A. https://orcid.org/0000-0003-3331-1529
License Information

Text and Data Mining valid from 2018-02-01
More Information

Article History

Received: 13 January 2018

Accepted: 18 January 2018

First Online: 1 February 2018

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.